Boothbay Fund Management’s Intersect ENT, Inc XENT Stock Holding History

Boothbay Fund Management’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-14,333	Closed	-$401K	–	2913
2022 Q1	$401K	Buy	+14,333	New	+$393K	0.01%	1423
2021 Q4	–	Sell	-9,293	Closed	-$253K	–	2416
2021 Q3	$253K	Sell	9,293 -5,789	-38%	-$143K	0.01%	1423
2021 Q2	$258K	Buy	15,082 +5,216	+53%	+$97.6K	0.01%	1376
2021 Q1	$206K	Buy	+9,866	New	+$228K	0.01%	1354

Boothbay Fund Management's XENT Position: Q2 2022 in Review

Boothbay Fund Management sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 14,333 shares — an estimated $401K sold.

Boothbay Fund Management first reported a position in XENT in Q1 2021 and held it in 4 quarters. The position peaked at $401K in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

Boothbay Fund Management reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
Boothbay Fund Management sold 14,333 Intersect ENT, Inc shares in Q2 2022, an estimated $401K.
Boothbay Fund Management first reported a position in Intersect ENT, Inc in Q1 2021 and held it in 4 quarters.
Boothbay Fund Management's Intersect ENT, Inc position peaked at $401K in Q1 2022.
0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Boothbay Fund Management's 13F filing for Q2 2022, filed 15 Aug 2022.